Abstract
BackgroundAntinuclear antibodies(ANA) occur in 80%–98% of systemic sclerosis(SSc) patients (pts), with different specificities. Anticentromere antibody(ACA), antitopoisomerase I(anti-Scl70) and anti-RNA polymerase III are the commonest and are included in the new...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
